Stryker (SYK) Curent Deferred Tax Liability (2009 - 2010)

Stryker's (SYK) quarterly Curent Deferred Tax Liability came in at $26.9 million in Q4 2010, up 11.62% year-on-year from $24.1 million in Q4 2009, and up 11.62% on a QoQ basis from $24.1 million in Q4 2009.

Stryker (SYK) Curent Deferred Tax Liability (2009 - 2010) Analysis & Trends

Stryker (SYK) has 2 years of Curent Deferred Tax Liability data on file, last reported at $26.9 million in Q4 2010.

  • On a quarterly basis, Curent Deferred Tax Liability rose 11.62% year-over-year to $26.9 million in Q4 2010; TTM through Dec 2010 was $26.9 million, a 11.62% increase from a year earlier, with the FY2010 full-year figure at $26.9 million, up 11.62% from the prior year.
  • Curent Deferred Tax Liability for Q4 2010 stood at $26.9 million, up from $24.1 million in the prior quarter.
  • Over the last five years, Curent Deferred Tax Liability for SYK reached as high as $26.9 million in Q4 2010 and fell as low as $24.1 million in Q4 2009.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2010 26.90 Mn
Dec 31, 2010 26.90 Mn
Dec 31, 2009 24.10 Mn
Dec 31, 2009 24.10 Mn